Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Pharmapack 2023 a Pivotal Moment for Sustainability in Drug Delivery and Packaging
Pharmapack Europe 2023 (February 1-2, 2023) closed earlier this month with the drug delivery and packaging […]
Illumina and Myriad Genetics Expand Partnership to Broaden Access to HRD Testing in the United States
Illumina, a global leader in DNA sequencing and array-based technologies, and Myriad Genetics, a leader […]
Kaia Health Becomes World's Most Broadly Covered Back Pain Offering After Gaining Approval for Prescription in Germany
Kaia Back Pain, a digital therapy for the treatment of non-specific back pain, has been […]
Prana Thoracic Announces Series A Financing
Prana Thoracic, a medical device company developing the first minimally invasive lung tissue excision tool […]
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy
Porton Advanced and DanausGT Biotechnology have announced a strategic collaboration in gene and cell therapy […]
Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
Sesen Bio, today announced that its stockholders have voted to approve all proposals, including the […]
Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer
Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, and Foundation […]
Sitero Appoints Jeff Huntsman as Chief Commercial Officer
Sitero is pleased to announce the addition of Jeff Huntsman to its growing leadership team […]
Results of CLDN18.2-targeting Immuno-PET Probe for Non-invasive Imaging in Gastrointestinal Tumors Published
Transcenta, a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing […]
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, announced today that Matthew […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more